Brief: Safety Shot Continues Scientific Development with Double-Blind Placebo-Controlled Trial Designed to Assess the Effects of Safety Shot on Blood and Breath Alcohol Levels
Nov 24 (Reuters) - Safety Shot Inc SHOT.O :
* SAFETY SHOT CONTINUES SCIENTIFIC DEVELOPMENT WITH
DOUBLE-BLIND
PLACEBO-CONTROLLED TRIAL DESIGNED TO ASSESS THE EFFECTS OF
SAFETY SHOT ON BLOOD AND BREATH ALCOHOL LEVELS
* SAFETY SHOT INC - PLANS TO LAUNCH BUSINESS-TO-BUSINESS
SALES OF
SAFETY SHOT TO DISTRIBUTORS, RETAILERS, RESTAURANTS, AND BARS IN
Q1 OF 2024
* SAFETY SHOT INC: SAFETY SHOT CLINICAL TRIAL TOPLINE DATA
EXPECTED Q1 2024
Source text for Eikon: ID:nGNX1DkYJn
Further company coverage: SHOT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bonk
See all newsBrief: Bonk Inc May Offer Up To $100 Million In Common Stock, Preferred Stock, Warrants, Rights, And Units - SEC Filing
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
Brief: Bonk, Inc. Reports Q3 Financial Results Emerges Debt-Free With $9 Million In Cash And 1,200% Revenue Growth
Brief: Safety Shot Changes Name To Bonk Inc